Lineage Cell Therapeutics, Inc. (LCTX) vs Sionna Therapeutics, Inc. (SION)

Lineage Cell Therapeutics, Inc. and Sionna Therapeutics, Inc. are both Biotechnology companies. Lineage Cell Therapeutics, Inc. and Sionna Therapeutics, Inc. are of similar size ($241.9M and $239.7M). Sionna Therapeutics, Inc. has the higher net margin (0.00% vs −246.6%) and the higher return on invested capital (−125.0% vs −186.8%). Across the 13 metrics below, Sionna Therapeutics, Inc. leads on 11 and Lineage Cell Therapeutics, Inc. on 2.

Valuation

Metric LCTX SION Biotechnology median
P/E n/m n/m 7.88
P/S 19.64 n/m 11.47
P/B 4.30 0.89 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 15.76 n/m 10.73
Earnings yield (13.96%) (41.68%) (28.84%)
Free cash flow yield (9.49%) (32.31%) (23.03%)

Profitability

Metric LCTX SION Biotechnology median
Gross margin 99.46% — 65.16%
Operating margin (205.23%) 0.00% 0.00%
Net margin (246.58%) 0.00% 0.00%
Free cash flow margin (186.43%) 0.00% 0.00%
Return on equity (60.35%) (32.34%) (57.72%)
Return on assets (32.75%) (30.66%) (49.22%)
Return on invested capital (186.79%) (125.00%) 0.00%

Growth

Metric LCTX SION Biotechnology median
Revenue growth (TTM) 19.87% — 5.64%
EPS growth (last fiscal year) (211.11%) 88.24% —
Revenue growth, 5-year CAGR 51.46% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric LCTX SION Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.61 20.05 4.73
Net debt to EBITDA 2.64 2.58 0.96

Dividend

Metric LCTX SION Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric LCTX SION Biotechnology median
Market cap 239.71m 241.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack